Drug major Ranbaxy today reported a net loss after tax and minority interest of Rs 464.58 crore for the quarter ended September 30, 2011, on account of foreign exchange losses.
The company had posted a net profit of Rs 307.93 crore for the quarter ended September 30, 2010, Ranbaxy Laboratories said.
Net sales of the company stood at Rs 2,022.75 crore in the quarter ended September 30, 2011, compared to Rs 1,877.48 crore in the same period of the previous fiscal.
Shares of Ranbaxy laboratories were being quoted at Rs 481 per share in afternoon trade on the BSE today, down 3.18% from their previous close.
